Rodrigues Dalva N, Siqueira Lucia H, Galizoni Andréa M, Arruda Valder R, Annichino-Bizzacchi Joyce M
Department of Pharmacology, Faculty of Medical Sciences, State University of Campinas (UNICAMP), CEP 13081-070 Campinas, SP, Brazil.
Blood Coagul Fibrinolysis. 2003 Apr;14(3):289-92. doi: 10.1097/01.mbc.0000061294.28953.42.
The prevalence of factor VII (FVII) deficiency in 267 Brazilian patients was estimated to be 4.1%, including one patient with significant bleeding, five with minor bleeding and five patients asymptomatic. Only one novel mutation 8926G <-- T (I140S) was seen in one patient. The other mutations were 10828G <-- A (R304Q) in three patients, 10846G <-- T (C310F) in one patient, and 10909G <-- A (G331D) in one patient. Except for one homozygous patient (C310F) with a severe deficiency, only one allele was affected in all other instances. An inverse association between F7 polymorphisms and FVII activity were found in these patients, as those with higher levels of FVII activity presented the genotype described in the literature as related to reduced FVII activity. As the R304Q mutation was the most frequent in these patients, and may be associated with an asymptomatic form of the disease, particularly in Blacks, we examined this mutation and FVII activity in 49 Blacks and 49 Caucasian blood donors with no clinical bleeding. None of the individuals showed the R304Q mutation, and FVII activity was normal in all of them, thus indicating that FVII deficiency is not common in normal individuals of these two ethnic groups in Brazil. This is the first study in South America to examine the prevalence and molecular basis of FVII deficiency, including the description of a novel mutation.
据估计,267名巴西患者中因子VII(FVII)缺乏症的患病率为4.1%,其中1例有严重出血,5例有轻微出血,5例无症状。仅1例患者出现了一个新的突变8926G<--T(I140S)。其他突变包括3例患者的10828G<--A(R304Q)、1例患者的10846G<--T(C310F)和1例患者的10909G<--A(G331D)。除1例纯合子患者(C310F)有严重缺乏外,其他所有病例仅一个等位基因受到影响。在这些患者中发现F7多态性与FVII活性呈负相关,因为FVII活性较高的患者呈现出文献中描述的与FVII活性降低相关的基因型。由于R304Q突变在这些患者中最为常见,且可能与无症状形式的疾病相关,尤其是在黑人中,我们在49名无临床出血的黑人及49名白人献血者中检测了该突变和FVII活性。所有个体均未显示R304Q突变,且他们的FVII活性均正常,这表明在巴西这两个种族的正常个体中FVII缺乏并不常见。这是南美洲第一项研究FVII缺乏症患病率及分子基础的研究,包括对一个新突变的描述。